Image Place holder

Iman Washington, MD


Specialty: Radiation Oncology
Program: Radiation Oncology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)


Locations: Moffitt Cancer Center
Moffitt McKinley Outpatient Center
Overview

Cancer Focus: Breast Cancer

Dr. Iman Washington is an Assistant Member in the Department of Radiation Oncology. She is a member of the Breast section in Radiation Oncology and the Moffitt Breast Program. Dr. Washington received her MD from Duke University School of Medicine, and completed a Preliminary Medicine Residency at Northwestern University/McGraw Medical Center in Chicago. Dr. Washington recently completed a Radiation Oncology Residency at The Ohio State University Wexner Medical Center In Columbus. Her clinical interests include early and locally advanced breast cancer, metastatic breast cancer, and techniques aimed at minimizing radiation-related normal tissue complications. Dr. Washington’s research interests include investigating factors that influence clinical and patient-reported breast cancer outcomes, improving cancer care for underserved populations, and applying new strategies to reduce the late effects of treatment for patients with breast cancer.  

Education & Training

Residency:

  • Northwestern University/McGraw Medical Center - Medicine
  • The Ohio State University Wexner Medical Center - Radiation Oncology

Medical School:

  • Duke University School of Medicine - MD
Participating Trials

CLINICAL TRIAL 20030
A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Condition: Breast
Intervention: Not Applicable
Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy. Breast Cancer Res Treat. 2019 Jun;175(3):781-788. Pubmedid: 30859348.
  • Ahmed KA, Liveringhouse CL, Mills MN, Figura NB, Grass GD, Washington IR, Harris EE, Czerniecki BJ, Blumencranz PW, Eschrich SA, Scott JG, Diaz R, Torres-Roca JF. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management. EBioMedicine. 2019 Aug;47:163-169. Pubmedid: 31416721.
  • Wright CL, Washington IR, Bhatt AD, Knopp MV. Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer. Semin Radiat Oncol. 2019 Apr;29(2):93-101. Pubmedid: 30827458.
  • Washington I, Chino JP, Marks LB, D'Amico TA, Berry MF, Ready NE, Higgins KA, Yoo DS, Kelsey CR. Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?. Thorac Cancer. 2013 May;4(2):123-130. Pubmedid: 28920196.
  • Lee CL, Moding EJ, Cuneo KC, Li Y, Sullivan JM, Mao L, Washington I, Jeffords LB, Rodrigues RC, Ma Y, Das S, Kontos CD, Kim Y, Rockman HA, Kirsch DG. p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal. 2012 Jul;5(234):ra52. Pubmedid: 22827996. Pmcid: PMC3533440.